“Vaccination against SARS-CoV-2 / COVID-19, with mRNA vaccines, is recommended for pregnant women in the second and third trimester. For the first trimester, vaccination may be considered after evaluation of the potential benefits and potential risks with the healthcare professional figure of reference “.
Vaccination is also recommended for women who are breastfeeding, without needing to stop it. This is what is indicated in a circular from the Ministry of Health just issued in the light of the growing evidence on efficacy and safety for both the fetus and the mother “.
The circular from the Ministry of Health has arrived today which “specifies” how pregnant women can have an experimental gene serum inoculated, but “to be evaluated” if in the first trimester of pregnancy.
What is not understood is why the only type of vaccine for future mothers should be mRNA technology: perhaps Pfizer BioNTech and Moderna have carried out and concluded scientifically valid experimental studies on voluntary pregnant women and control groups?
And have they already had time and time to monitor all the risks and benefits for women in the second and third trimesters?
The European Society of Human Reproduction and Embryology (Eshre) in June specified how “There is a lack of information on the possible effect of COVID-19 vaccination on assisted reproductive treatment or on future pregnancy. As a result, it is not possible to provide general recommendations that men and women attempting to conceive through assisted reproduction can receive the vaccine before start treatment “. L’Eshre pointed out how “For women with comorbidities that put them at increased risk of COVID-19 and / or complications of pregnancy, encouragement to vaccination should be considered before attempting to conceive. The same is true for women in whom the risk of exposure to SARS-CoV-2 infection is high and cannot be avoided. ” Regarding the best timing “there are different points of view on the hypothesis of postponing conception after vaccination. It seems prudent to do this for at least a few days after the completion of the vaccination (ie after the second dose) to allow time for the response immune stabilization “.
Has something changed?
The woman who is expecting a baby, as our grandmothers knew very well and as ALL the preparation course teams recommend, must not take drugs during pregnancy and breastfeeding, she must be very careful about nutrition (more than how our mothers did. ), must not drink or smoke or eat raw food.
Every woman knows this.
And they are advice handed down for centuries, endorsed by medicine today.
There are insufficient solid data to be able to assess the risk-benefit ratio.
There is no significant case history of pregnant women who died of covid, nor of vaccine-related adverse reactions reported for the pregnant mother and child, and finally there are no analyzes on the milk of mothers.
There is no scientific study on the subject worthy of dignity and with solid data.
And also the site “Epidemiology for public health – ISS”, not the usual gomblottista no vax, offers specific indications for the vaccination of pregnant and breastfeeding women.
We report in full the information on
“Vaccination against COVID-19 in pregnancy and breastfeeding
The concern of undergoing vaccination during pregnancy and lactation, in the absence of safety and efficacy data of vaccines against COVID-19 for this target population, is the subject of debate nationally and internationally. The indications of the various countries provide for the vaccination offer for these women subject to an individual assessment of the risk / benefit profile, facilitated by an informative interview with health professionals.
In Italy, the Italian Obstetric Surveillance System (ItOSS) of the Istituto Superiore di Sanità (ISS) examines the interim indications, taken at an international and national level, and the scientific evidence on the subject, producing documents shared and signed by the main scientific societies in the sector (the Italian Society of Gynecology and Obstetrics, SIGO, the Association of Italian Hospital Obstetricians and Gynecologists, AOGOI, the Italian University Gynecologists Association, AGUI, the Territorial Gynecologists Association, AGITE, the National Federation of Obstetric Colleges, FNOPO, the Italian Society of Neonatology, SIN, the Italian Society of Perinatal Medicine, SIMP, the Italian Society of Pediatrics, SIP, the Cultural Association of Pediatricians, ACP, the Italian Society of Anesthesia, Analgesia, Intensive Care and Intensive Care, SIAARTI) . The first document, published on 9 January 2021, is replaced by the update on 31 January, which takes stock of the EMA’s authorization for the marketing of the AstraZeneca vaccine in Europe for subjects over 18 years of age. age; on the interim recommendations for the use of the COVID-19 Moderna mRNA-1273 vaccine published by the WHO Strategic Advisory Group of Experts on Immunization (SAGE) and on the confirmation by the Canadian Society of Obstetrics and Gynecology (SOGC) of the statement of consent to the use of vaccines against COVID in pregnancy and breastfeeding.
The goal of the ISS indications is to support healthcare professionals and pregnant and lactating women in the decision-making process during the COVID-19 pandemic.
Among the Italian interim indications relating to the Pfizer-BioNtech mRNA vaccine (Comirnaty), the Moderna vaccine and the AstraZeneca vaccine in pregnancy and lactation are analyzed: the safety of the vaccine for mothers and newborns; the potential risks of COVID-19 disease in the mother, including possible effects on the fetus / newborn; the individual risk of contracting the infection in consideration of possible comorbidities; the level of activity of the pandemic in the target community and in the woman’s workplace.
These are the interim indications as of January 31, 2021.
“Pregnant and breastfeeding women were not included in the evaluation trials of Pfizer-BioNtech mRNA (Comirnaty), Moderna and AstraZeneca vaccines so we do not have safety and efficacy data for these people. Studies conducted so far have not shown nor suggested biological mechanisms that could associate mRNA vaccines with adverse effects in pregnancy and laboratory evidence on animals suggests the absence of vaccination risk
currently pregnant and breastfeeding women are not a priority target of the COVID-19 vaccination offer which, to date, is not routinely recommended for these people
from the data of the ItOSS study – relating to the first pandemic wave in Italy – it emerges that pregnant women have a low risk of serious maternal and perinatal outcomes and that previous co-morbidities (hypertension, obesity) and non-Italian citizenship are significantly associated with a greater risk of serious complications from COVID-19.
vaccination should be considered for pregnant women who are at high risk for serious complications from COVID19.
Women in these conditions must evaluate the potential benefits and risks with the healthcare professionals who assist them and the choice must be made on a case-by-case basis.
_ if a vaccinated woman discovers that she is pregnant soon after vaccination, there is no evidence in favor of termination of the pregnancy
_ if a woman discovers that she is pregnant between the first and second dose of the vaccine, she can postpone the second dose after the termination of pregnancy, except for subjects at other risk
_ Breastfeeding women can be included in the vaccination offer without having to stop breastfeeding. “
And even one of the star virologists like Crisanti, in Tagada today, did not want to take on the responsibility of validating and recommending the testing of the serum to expectant mothers. “Vaccine in pregnancy?” I would wait, there is not enough data yet “